Blocking Angiotensin II Type 1 Receptor Triggers Apoptotic Cell Death in Human Pancreatic Cancer Cells

Pancreas ◽  
2010 ◽  
Vol 39 (5) ◽  
pp. 581-594 ◽  
Author(s):  
Qiaoke Gong ◽  
Molly Davis ◽  
Galina Chipitsyna ◽  
Charles J. Yeo ◽  
Hwyda A. Arafat
Keyword(s):  
Pancreatic Cancer ◽  
Cell Death ◽  
Angiotensin Ii ◽  
Cancer Cells ◽  
Apoptotic Cell ◽  
Apoptotic Cell Death ◽  
Human Pancreatic Cancer ◽  
Pancreatic Cancer Cells

A novel anti-tumor agent, polyoxomolybdate induces apoptotic cell death in AsPC-1 human pancreatic cancer cells

2005 ◽  
Vol 59 (5) ◽  
pp. 240-244 ◽  
Author(s):  
A. Ogata ◽  
S. Mitsui ◽  
H. Yanagie ◽  
H. Kasano ◽  
T. Hisa ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cell Death ◽  
Cancer Cells ◽  
Apoptotic Cell ◽  
Apoptotic Cell Death ◽  
Human Pancreatic Cancer ◽  
Pancreatic Cancer Cells ◽  
Tumor Agent

P33. HSP70 Inhibition Sensitizes to Trail Induced Apoptotic Cell Death in Pancreatic Cancer Cells

2008 ◽  
Vol 144 (2) ◽  
pp. 448
Author(s):  
Daniel Borja-Cacho ◽  
Pawel Zwolak ◽  
Vikas Dudeja ◽  
Rajinder K. Dawra ◽  
Jacob S. Ankeny ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cell Death ◽  
Cancer Cells ◽  
Apoptotic Cell ◽  
Apoptotic Cell Death ◽  
Pancreatic Cancer Cells

QS308. HSP70 Inhibition Sensitizes to TRAIL Induced Apoptotic Cell Death in Pancreatic Cancer Cells

2008 ◽  
Vol 144 (2) ◽  
pp. 389
Author(s):  
Daniel Borja-Cacho ◽  
Pawel Zwolak ◽  
Vikas Dudeja ◽  
Rajinder K. Dawra ◽  
Jacob S. Ankeny ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cell Death ◽  
Cancer Cells ◽  
Apoptotic Cell ◽  
Apoptotic Cell Death ◽  
Pancreatic Cancer Cells

Angiotensin II Type 1 Receptor Blockade Does Not Enhance Apoptotic Cell Death During Ischemia and Reperfusion in Humans In Vivo

2011 ◽  
Vol 57 (6) ◽  
pp. 702-706 ◽  
Author(s):  
Patrick Meijer ◽  
Constantijn W Wouters ◽  
Wim J Oyen ◽  
Otto C Boerman ◽  
Gert Jan Scheffer ◽  
...  
Keyword(s):  
Cell Death ◽  
Angiotensin Ii ◽  
Apoptotic Cell ◽  
Apoptotic Cell Death ◽  
Receptor Blockade ◽  
Ischemia And Reperfusion

Plumbagin, Isolated from Plumbago zeylanica, Induces Cell Death through Apoptosis in Human Pancreatic Cancer Cells

Pancreatology ◽  
2009 ◽  
Vol 9 (6) ◽  
pp. 797-809 ◽  
Author(s):  
Chien-An Chen ◽  
Hen-Hong Chang ◽  
Chung-Yu Kao ◽  
Tung-Hu Tsai ◽  
Yu-Jen Chen
Keyword(s):  
Pancreatic Cancer ◽  
Cell Death ◽  
Cancer Cells ◽  
Human Pancreatic Cancer ◽  
Plumbago Zeylanica ◽  
Pancreatic Cancer Cells

Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines

2009 ◽  
Vol 25 (3) ◽  
pp. 210-219 ◽  
Author(s):  
Satoko Adachi ◽  
Satoshi Kokura ◽  
Tetsuya Okayama ◽  
Takeshi Ishikawa ◽  
Tomohisa Takagi ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cell Death ◽  
Cell Lines ◽  
Cancer Cell ◽  
Pancreatic Cancer Cell ◽  
Apoptotic Cell ◽  
Cancer Cell Lines ◽  
Apoptotic Cell Death ◽  
Human Pancreatic Cancer ◽  
Human Pancreatic Cancer Cell

scholarly journals Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer

Cancers ◽  
2021 ◽  
Vol 13 (16) ◽  
pp. 4173
Author(s):  
Faustino Mollinedo ◽  
Consuelo Gajate
Keyword(s):  
Pancreatic Cancer ◽  
Endoplasmic Reticulum ◽  
Cell Death ◽  
Er Stress ◽  
Cancer Cells ◽  
Tumor Cells ◽  
Apoptotic Cell ◽  
Ether Lipid ◽  
Ductal Adenocarcinoma ◽  
Pancreatic Cancer Cells

Pancreatic ductal adenocarcinoma (PDAC), the most common malignancy of the pancreas, shows a dismal and grim overall prognosis and survival rate, which have remained virtually unchanged for over half a century. PDAC is the most lethal of all cancers, with the highest mortality-to-incidence ratio. PDAC responds poorly to current therapies and remains an incurable malignancy. Therefore, novel therapeutic targets and drugs are urgently needed for pancreatic cancer treatment. Selective induction of apoptosis in cancer cells is an appealing approach in cancer therapy. Apoptotic cell death is highly regulated by different signaling routes that involve a variety of subcellular organelles. Endoplasmic reticulum (ER) stress acts as a double-edged sword at the interface of cell survival and death. Pancreatic cells exhibit high hormone and enzyme secretory functions, and thereby show a highly developed ER. Thus, pancreatic cancer cells display a prominent ER. Solid tumors have to cope with adverse situations in which hypoxia, lack of certain nutrients, and the action of certain antitumor agents lead to a complex interplay and crosstalk between ER stress and autophagy—the latter acting as an adaptive survival response. ER stress also mediates cell death induced by a number of anticancer drugs and experimental conditions, highlighting the pivotal role of ER stress in modulating cell fate. The alkylphospholipid analog prototype edelfosine is selectively taken up by tumor cells, accumulates in the ER of a number of human solid tumor cells—including pancreatic cancer cells—and promotes apoptosis through a persistent ER-stress-mediated mechanism both in vitro and in vivo. Here, we discuss and propose that direct ER targeting may be a promising approach in the therapy of pancreatic cancer, opening up a new avenue for the treatment of this currently incurable and deadly cancer. Furthermore, because autophagy acts as a cytoprotective response to ER stress, potentiation of the triggering of a persistent ER response by combination therapy, together with the use of autophagy blockers, could improve the current gloomy expectations for finding a cure for this type of cancer.

Sign in / Sign up

Export Citation Format

Share Document